Use of Globifer Forte (Haem Iron) Tablets against Iron Deficiency Anaemia (IDA) during Pregnancy

The aim of this study was to assess the efficacy of Globifert forte in pregnant women with IDA.

A lower level of iron in the human body causes anaemia, which is defined as a reduction in the number of red blood cells (RBCs) or haemoglobin. This study was conducted to assess the efficacy of Globifert forte (oral iron intake) in treating pregnant patients with iron deficiency anaemia (IDA). A relatively new medication called Globifert Forte is taken orally to treat anaemia and IDA. Globifert forte oral administration has some restrictions. Blood transfusions are only to be used in the most severe cases of symptomatic anaemia as a last resort.

This is a prospective, single centre, open and non-comparator study in Lamis Clinic and Said Hospital, Misurata, Libya. We included a total of 100 pregnant ladies with IDA for a time period of 12 weeks. In this prospective study 100 pregnant women were involved. All of them were given Globifert fort tablets during the study period of 12 weeks.

Hb level have reached the target level within a short period of time with very minor side effects or discomfort. Side effects of oral iron supplements had not been seen during the study time such as gastrointestinal effect, thus showing the safety of the drug in the pregnant women and its acceptance from the patients.

Globifert forte has been found very suitable, effective and convenient in treatment of IDA during antenatal care. This study revealed significant improvement of anemia as Hb level and its symptoms in pregnant women given calculated dose of Globifert forte tablets. It was safe, tolerable and well accepted.